CellFE Launches T-REST Kit: Revolutionizing CAR-T Cell Therapy Manufacturing for Breakthrough Cancer Treatments
CellFE, a pioneering biotechnology company, has unveiled its groundbreaking T-REST Resting T Cell Kit, a first-in-class solution designed to revolutionize CAR-T cell therapy manufacturing. This innovative kit aims to enhance the quality and efficacy of CAR-T therapies by optimizing the resting state of T cells, a critical factor in improving patient outcomes. By addressing key […]